AstraZeneca says US trial data shows vaccine 79% effective

Advanced trial data from a U.S. study on the AstraZeneca COVID-19 vaccine shows it is 79% effective, the company announced Monday in long-awaited research that may answer some questions about the shot's effectiveness in older populations.